Condition
CMT1A
Total Trials
6
Recruiting
4
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Recruiting4
Unknown1
Terminated1
Clinical Trials (6)
Showing 6 of 6 trials
NCT07570446Recruiting
AUTONOMOUS DISORDERS IN CMT
NCT07476365Recruiting
A Multi-omic Approach to the Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease (CMT1A)
NCT07461896Recruiting
Studying Nerve Function and Structure in Charcot-Marie-Tooth Disease, Anti-MAG Neuropathy and CIDP
NCT06794489RecruitingPrimary
Longitudinal Biomarkers With Selected Outcome Measures In CMT
NCT02600286Phase 2TerminatedPrimary
Ulipristal Acetate In Disease Charcot-Marie-Tooth Type of 1A
NCT03278093Unknown
Effect of Orthoses and Underfoot Vibration on Balance in Neuropathy
Showing all 6 trials